Novel Irreversible Inhibitors of Epidermal Growth Factor Receptor Tyrosine Kinase and Uses Thereof for Therapy and Diagnosis

Details for Australian Patent Application No. 2005203167 (hide)

Owner T.K. Signal Ltd.

Inventors Levitzki, Alexander; Abourbeh, Galith; Rozen, Yulia; Mishani, Eyal

Agent Cullen & Co

Pub. Number AU-A-2005203167

Parent 2004206142

Filing date 21 July 2005

Wipo publication date 25 August 2005

International Classifications

C07D 239/88 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61P 035/00 Antineoplastic agents

A61K 031/517 - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

C07D 239/94 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/93 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

4 August 2005 Complete Application Filed

25 August 2005 Application Open to Public Inspection

  Published as AU-A-2005203167

24 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005203168-Method of protecting wood through enhanced penetration of wood preservatives and a related solution

2005203166-A Combined Floating S. Seal System